GlaxoSmithKline
GSK
#234
Rank
A$122.83 B
Marketcap
$60.48
Share price
-6.33%
Change (1 day)
-4.36%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $5.27

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $5.79. In 2022 the company made an earnings per share (EPS) of $14.04 an increase over its 2021 EPS that were of $4.95.

EPS history for GlaxoSmithKline from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.27-62.45%
2022$14.04183.39%
2021$4.95-17.83%
2020$6.0321.82%
2019$4.9523.91%
2018$3.99141.48%
2017$1.6564.6%
2016$1.00-90.64%
2015$10.73178.14%
2014$3.86-48.16%
2013$7.4422.63%
2012$6.07-11.32%
2011$6.84230.25%
2010$2.07-70.98%
2009$7.146.76%
2008$6.69-15.14%
2007$7.887.82%
2006$7.3119.61%
2005$6.1118.56%
2004$5.160.36%
2003$5.1450.39%
2002$3.4231.13%
2001$2.61-25.43%
2000$3.4931.58%
1999$2.661.05%
1998$2.63-0.98%
1997$2.65-10.07%
1996$2.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.29-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.08-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.02-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.19 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.26-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
-$3.31-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.44-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA